National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors.

about

National Rise of Primary Pancreatic Carcinoid Tumors: Comparison to Functional and Nonfunctional Pancreatic Neuroendocrine Tumors.

Item

http://www.wikidata.org/entity/Q39104152

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

National Rise of Primary Pancr ...... creatic Neuroendocrine Tumors.

@en

National Rise of Primary Pancr ...... creatic Neuroendocrine Tumors.

@nl

type

Item

label

National Rise of Primary Pancr ...... creatic Neuroendocrine Tumors.

@en

National Rise of Primary Pancr ...... creatic Neuroendocrine Tumors.

@nl

prefLabel

National Rise of Primary Pancr ...... creatic Neuroendocrine Tumors.

@en

National Rise of Primary Pancr ...... creatic Neuroendocrine Tumors.

@nl

P1476

National Rise of Primary Pancr ...... creatic Neuroendocrine Tumors.

@en

P2093

Abhishek Tadikonda

http://www.w3.org/2001/XMLSchema#string

Gyulnara G Kasumova

http://www.w3.org/2001/XMLSchema#string

Jennifer F Tseng

http://www.w3.org/2001/XMLSchema#string

Mariam F Eskander

http://www.w3.org/2001/XMLSchema#string

Sing Chau Ng

http://www.w3.org/2001/XMLSchema#string

P2860

The National Cancer Data Base: a powerful initiative to improve cancer care in the United States

Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.

Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs

A 5-decade analysis of 13,715 carcinoid tumors.

Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs).

Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting.

Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.

Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.

Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?

Serotonin-producing enterochromaffin cell tumors of the pancreas: clinicopathologic study of 15 cases and comparison with intestinal enterochromaffin cell tumors.

P304

1057-1064

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JAMCOLLSURG.2016.11.014

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

224

http://www.w3.org/2001/XMLSchema#string

P50

Omidreza Tabatabaie

P577

2016-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27965134

http://www.w3.org/2001/XMLSchema#string

P932

5446922

http://www.w3.org/2001/XMLSchema#string